Andrea Kazumi Shimada

6PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersCancer geneticsModels of care and place of birthBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 06, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).

Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo

|Jan 30, 2026
Cost-Effectiveness of the Oncotype DX Breast Recurrence Score Test in the Brazilian Private Health Care Sector.

Ivan Zimmermann, Carlos Alberto da Silva Magliano, Leandro Jonata de Carvalho Oliveira

|Oct 22, 2025
Budget Impact of the Oncotype DX Test in Early-Stage Breast Cancer for the Brazilian Private Health Care System.

Carlos Alberto da Silva Magliano, Ivan R Zimmermann, Leandro Jonata de Carvalho Oliveira

|Oct 08, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil.

Romualdo Barroso-Sousa, Danielle Laperche-Santos, Heloisa Resende

|Apr 18, 2025
Adherence to Adjuvant Endocrine Therapy in Patients With Nonmetastatic Estrogen Receptor-Positive Breast Cancer: A Comprehensive Brazilian Real-World Data Study.

Daniele Assad-Suzuki, Danielle Laperche-Santos, Heloisa Resende

|Jan 15, 2025
Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120).

Mauro Zukin, Victor Gondim, Andrea Kazumi Shimada

Pageof 1

Frequent Collaborators

5 joint publications

Daniele Assad-Suzuki

3 joint publications

Leandro Jonata de Carvalho Oliveira

3 joint publications

Carlos Henrique Dos Anjos

3 joint publications

Max Senna Mano